The MOOC “Understanding and Living with Myeloma” was developed by the AF3M, a nonprofit organization founded in 2007 by 27 patients and relatives. As of today, this association includes more than 2000 members and over 100 volunteers and has held ministerial recognition since 2012. Its missions include providing information and support to patients and caregivers, advocating for patient rights, promoting public awareness of MM, supporting research, and facilitating therapeutic education initiatives across France. To promote access to reliable information and empower patients to better manage their illness, the AF3M made the decision to innovate through digital education. In response to the growing relevance of online learning, it initiated the development of this MOOC dedicated specifically to patients. The French-Speaking Myeloma Intergroup (IFM), a cooperative clinical and research network created in 1994, partnered with the AF3M on this project. The IFM includes hematologists, clinicians, and biologists in France and has been instrumental in conducting large-scale clinical trials and advancing both basic and translational myeloma research.

Expertise in pedagogical engineering, audiovisual production, and digital learning design was provided by HB Motion, an educational media company. The project received institutional support from the Janssen laboratory (Johnson & Johnson Group). A steering committee was established, initially composed of patients and caregivers, and subsequently expanded to include members of the AF3M’s scientific board, comprising approximately 30 health care professionals affiliated with the IFM. The final project team consisted of a dozen AF3M volunteers, patients, relatives, and multimedia learning engineers, who worked in close collaboration to create content tailored to patient needs (Textbox 1). Participants were recruited between September 2018 and October 2018 through the AF3M networks. Announcements were systematically disseminated via AF3M’s website, newsletters, hospital hematology departments, and social media. No exclusion criteria were applied other than language proficiency in French and internet access. Enrollment was open to all interested participants via online registration. Recruitment was therefore open and national in scope, ensuring representation from various French regions. Participation in the MOOC was also open to caregivers and health professionals wishing to deepen their understanding of the disease, therapeutic approaches, and patient-centered challenges. The MOOC was officially launched during the National Myeloma Information Day in 2018. A self-assessment questionnaire at the start of the MOOC had to be completed online. The questions were about initial knowledge and skills. The same questionnaire was administered again at the end of the MOOC to participants who completed the entire program. The pre-MOOC and post-MOOC self-assessments of the 2018 edition were analyzed and compared.

All statistical analyses were conducted using Bioconductor packages in the R programming language (R Core Team). The unpaired Wilcoxon test was used to compare pre- and posttest continuous variables, and Fisher exact test was used for categorical variables. All statistical tests were 2-sided, and P values less than or equal to .05 were considered statistically significant.

This study did not involve any biomedical experimentation or collection of identifiable personal data. Under French law, only research involving the human person (RIPH) requires prior review by an Institutional Review Board. RIPH is legally defined as research that is organized and conducted on persons with the aim of developing biological or medical knowledge (French Public Health Code Article R1121-1) [13]. This study consisted of the evaluation of an educational program developed for patients with MM and their caregivers by the AF3M in collaboration with the IFM using anonymized self-assessment questionnaires and did not entail any biomedical intervention, randomization, or modification of usual care. It therefore falls outside the scope of RIPH and did not require the Ethics Committee for the protection of persons review under the applicable framework. National guidance issued by the French National Agency for Medicines and Health Products Safety (ANSM) confirms that such noninterventional educational evaluations are exempt from ethics committees for the protection of persons’ authorization. Data were anonymized before analysis, and data processing complied with the European General Data Protection Regulation and the French Data Protection Act. Participation was voluntary, and all users provided electronic informed consent when registering on the MOOC platform.

Following the survey sent by email to all AF3M members, 398 responses were obtained from 344 patients with MM (86%), 47 relatives (12%), and 7 (2%) health professionals. The average age of patients with MM was 64.8 years (range 32‐86), with 54% being male. Only 10 patients (3%) had participated previously in TPE programs. Responses were geographically distributed across the country. The median follow-up of patients with MM was 5 years. Respondents expressed their expectations regarding knowledge, skills, and attitudes to be developed to improve the management of the disease. In total, 68% (n=270) of respondents said they were interested in the MOOC project. The classification of attitudes that patients wished to develop was optimism (71.9%), resilience (62.7%), fighting spirit (57%), self-confidence (56%), autonomy (55%), courage (46%), attention to relatives (46%), perseverance (39%), attention to medical prescriptions (36%), listening skills (35%), communication (34%), self-control (33%), adaptability (27%), and organization (17%).

The educational path includes 5 modules that are divided into 15 stages over a period of 8 weeks for each session of the MOOC (Textbox 2). All modules contain short videos, patient testimonials, interviews with health professionals, and analyses conducted from real situations. The modules end with a challenge, a summary, a quiz, feedback on the proposed activities, an assessment of the skills acquired, and a validation badge. At the end of each module, participants can attend a thematic web conference, led by a health care professional and an AF3M representative, where they can ask questions by webchat. These exchanges are able to be replayed. The interactive MOOC is tutored by peers and AF3M volunteers. From the second session, the tutors are accompanied and supported by an onco-psychologist to help enable them to handle any emergency situations. When registering for the MOOC, participants complete a questionnaire on demographic characteristics (Table 1).

At the first edition of the MOOC, 30% of participants (76/254) completed all modules (Figure 1), and 98% of participants rated this training as satisfactory or very satisfactory, and 99% would recommend this MOOC to other people. The results regarding the satisfaction rates are summarized in Table 2. The different sessions gave rise to many exchanges between the participants and the volunteer tutors responsible for responding to and encouraging them. In total, more than 7500 contributions (questions and messages) have been published. This MOOC has been conducted 6 times at different periods, with a cumulative enrollment of 2400 participants. This knowledge assessment was conducted only during the first session.

General knowledge of MM, warning signs, treatments, know-how, and skills (52 items in total) was assessed by the patients themselves before starting the MOOC (n=288) and at the end of the training (n=76) by scoring items from 1 to 5 (5 representing excellent knowledge) (Figure 2). Mean knowledge scores improved from 3.06/5 pretest to 4.21/5 posttest (gain of +1.15, 38%; P<.001) (Table 3).

The interactive online conferences brought together an average of 100 participants and are widely consulted in replay. An expert is interviewed by a mediator for one hour. During the COVID-19 pandemic, which further exacerbated existing anxiety and concerns among patients with MM, the AF3M provided help and support to them and their families during this exceptional health crisis. In response, the AF3M hosted web conferences on COVID-19. In total, 600 people registered for the first web conference, which was substantially more than the expected amount (Table 4). This outcome confirmed the importance of opening a virtual space for patients with hemopathies to ask questions and obtain answers from experts and from cooperative groups. The level of satisfaction rose to 98% by the third web conference. These web conferences delivered clear information, enhanced knowledge, enabled interaction with experts, and addressed COVID-19 from medical, psychological, legal, and social perspectives.

This MOOC represents one of the first educational platforms specifically designed to support patients with MM and their relatives. Completion of the MOOC led to a substantial improvement in participants’ understanding of MM, including disease mechanisms, warning signs, available treatments, and self-management skills. The mean knowledge score rose from 3.06 to 4.21 out of 5, a+38% increase (P<.001), confirming the educational effectiveness of the program.

Developed in collaboration with patients and health care professionals, it addresses key needs, including access to scientifically validated information, support in coping with treatment-related challenges, and the opportunity to share experiences within a safe, anonymous, and interactive environment. This initiative offers important advantages. It provides free and accessible information to patients across all geographic areas, including those who may be isolated or far from specialist centers. The platform fosters open peer-to-peer and patient-expert discussions. The inclusion of web conferences and replays further enhances the value of the program, allowing patients to engage in real time or at their convenience. Additional strengths are the availability of web conferences, interactive exchanges, and tutoring. The overwhelmingly positive feedback and high satisfaction rates observed across four conference editions demonstrate both the relevance and the acceptability of this digital educational tool. Our findings align with and expand upon previous work demonstrating the value of digital and co-designed educational interventions for patients with chronic diseases [7]. Similar knowledge gains were observed in oncology-focused MOOCs, such as the program described for women with breast cancer, where a participatory design approach improved digital health literacy and engagement [10]. Comparable improvements in knowledge (25%‐40%) have been reported in other chronic conditions, including the MOOC-osteoarthritis trial for osteoarthritis and the MyRelief self-management platform for persistent low back pain [8]. These results collectively suggest that structured, user-centered digital education can promote understanding, self-efficacy, and behavioral adaptation across diverse patient populations.

In contrast to most previously published MOOCs, which primarily targeted health care professionals or single disease educational objectives, our study uniquely focused on patients with a specific hematologic malignancy and actively involved caregivers and advocacy groups from the outset. This co-construction process with AF3M and IFM ensured content relevance, scientific accuracy, and a strong sense of community ownership. The 38% relative improvement in knowledge and very high satisfaction rate (98%) are therefore consistent with the literature while confirming the added value of participatory design and peer tutoring in enhancing engagement.

Furthermore, our results support evidence that interactive components, such as web conferences, discussion forums, and tutor guidance, substantially increase learning outcomes and emotional support compared with passive e-learning formats. These findings reinforce earlier observations from geriatric oncology and bariatric surgery MOOCs, in which interactivity and peer exchange were key determinants of user satisfaction. Together, these comparisons highlight that the present MOOC not only replicates but also extends existing evidence by demonstrating that co-designed digital education can be successfully implemented and sustained in a complex oncologic setting.

Nevertheless, several limitations must be acknowledged. First, the digital nature of the program poses challenges for some patients. Barriers include limited access to computers or mobile devices, unfamiliarity with digital tools, or language limitations, as the MOOC is only available in French. This is particularly relevant in MM, a disease that predominantly affects older patients, some of whom may also experience physical or cognitive impairments (neuropathy, fatigue, or pain) that can interfere with concentration and learning. While basic computer literacy is required, the presence of peer tutors and access to technical tutorials aim to mitigate these barriers. Second, the potential for selection bias must be considered. Participants were largely recruited through the AF3M’s network, likely including patients already motivated to learn more about their condition. In addition, self-assessment questionnaires, while informative, are subjective in nature and were developed by the team involved in designing the MOOC, raising concerns about possible measurement bias [14]. Although more objective outcome measures (quality of life and adherence) would strengthen the evaluation, such endpoints typically require a clinical trial framework [14]. As commonly observed in MOOC-based learning, we noted a progressive decrease in participant engagement over time. Only 30% of learners completed the full program.

Interestingly, the 10 hours of structured patient education provided by the MOOC may, indirectly, allow clinicians to focus on more personalized and specific aspects of care during consultations. In this way, the MOOC complements rather than replaces the essential in-person interactions with medical and paramedical teams. Beyond knowledge acquisition, this program may also support emotional well-being, enhance patient autonomy, and foster a sense of community among participants. The platform also proved highly adaptable, offering timely content during the COVID-19 pandemic, when patients’ anxiety was heightened and access to care was disrupted. This success of the web conferences underlined the critical importance of offering a virtual space for reliable, empathetic, and timely medical communication.

MOOCs represent a flexible and scalable solution for therapeutic education, allowing for regular updates as scientific knowledge evolves and offering a customizable approach that supports patients throughout their care journey, from diagnosis to long-term follow-up. The key advantages include access to scientifically validated information, flexibility to learn at one’s own pace, and the opportunity to revisit content as needed. Remaining questions concern the long-term impact of such programs on clinical outcomes, adherence, and quality of life. Beyond improving knowledge and engagement, this MOOC fosters patient self-management and strengthens the partnership between patients and health care professionals. Its success underscores the importance of co-designing educational resources with patients and highlights the potential of digital platforms to advance chronic disease care in a sustainable, equitable, and patient-centered manner. The program was highly valued by users and demonstrates the feasibility of large-scale digital patient education in oncology. Its design and outcomes may serve as a model for future digital health education initiatives targeting other chronic diseases.